Neurologic Clinic and Policlinic, Departments of Medicine, Clinical Research and Biomedical Engineering, Department of Neurology, University Hospital Basel and University of Basel, Petersgraben 4, 4031, Basel, Switzerland.
Medical Image Analysis Center AG, Basel, Switzerland.
J Neurol. 2020 May;267(5):1536-1546. doi: 10.1007/s00415-020-09740-4. Epub 2020 Feb 10.
Volume loss in the deep gray matter (DGM) has been reported in patients with multiple sclerosis (MS) already at early stages of the disease and is thought to progress throughout the disease course.
To investigate the impact and predictive value of volume loss in DGM and thalamic subnuclei on disability worsening in patients MS over a 6-year follow-up period.
Hundred and seventy-nine patients with RRMS (132 women; median Expanded Disability Status Scale, EDSS: 2.5) and 50 with SPMS (27 women; median EDSS: 4.5) were included in the study. Patients underwent annual EDSS assessments and annual MRI at 1.5 T. DGM/thalamic subnuclei volumes were identified on high-resolution T1-weighted. A hierarchical linear mixed model for each anatomical DGM area and each thalamic subnucleus was performed to investigate the associations with disability scores. Cox regression was used to estimate the predictive properties of volume loss in DGM and thalamic subnuclei on disease worsening.
In the whole sample and in RRMS, volumes of the thalamus and the striatum were associated with the EDSS; however, only thalamic volume loss was associated with EDSS change at follow-up. Regarding thalamic subnuclei, volume loss in the anterior nucleus, the pulvinar and the ventral anterior nucleus was associated with EDSS change in the whole cohort. A trend was observed for the ventral lateral nucleus. Volume loss in the anterior and ventral anterior nuclei was associated with EDSS change over time in patients with RRMS. Moreover, MS phenotype and annual rates of volume loss in the thalamus and ventral lateral nucleus were predictive of disability worsening.
These results highlight the relevance of volume loss in the thalamus as a key metric for predicting disability worsening as assessed by EDSS (in RRMS). Moreover, the volume loss in specific nuclei such as the ventral lateral nucleus seems to play a role in disability worsening.
多发性硬化症(MS)患者在疾病早期就已经出现深部灰质(DGM)体积损失,并且据认为这种损失会在整个病程中进展。
在 6 年的随访期间,研究 DGM 和丘脑亚核体积损失对 MS 患者残疾恶化的影响和预测价值。
本研究纳入了 179 例 RRMS 患者(132 例女性;中位扩展残疾状态量表,EDSS:2.5)和 50 例 SPMS 患者(27 例女性;中位 EDSS:4.5)。患者接受了年度 EDSS 评估和 1.5T 年度 MRI。在高分辨率 T1 加权图像上识别 DGM/丘脑亚核体积。对每个解剖 DGM 区域和每个丘脑亚核进行层次线性混合模型分析,以研究与残疾评分的关联。使用 Cox 回归估计 DGM 和丘脑亚核体积损失对疾病恶化的预测性能。
在整个样本和 RRMS 中,丘脑和纹状体的体积与 EDSS 相关;然而,只有丘脑体积损失与随访时的 EDSS 变化相关。关于丘脑亚核,前核、豆状核和腹前核的体积损失与整个队列的 EDSS 变化相关。腹外侧核也有趋势。RRMS 患者的前核和腹前核体积损失与 EDSS 随时间的变化相关。此外,MS 表型和丘脑及腹侧外侧核的年度体积损失率与残疾恶化相关。
这些结果强调了丘脑体积损失作为预测 EDSS 评估残疾恶化的关键指标的重要性(在 RRMS 中)。此外,特定核如腹侧外侧核的体积损失似乎在残疾恶化中起作用。